Research progress of axillary de-escalation management after neoadjuvant chemotherapy for clinical lymph node positive patients

In the era of effective systemic therapy and precise radiotherapy, neoadjuvant treatment (NAT) for breast cancer can de-escalate breast cancer treatment to conserve breast and spare axillary lymph node dissection (ALND). At present, high axillary nodal pathologic complete response (apCR) is achieved...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Qingda FAN, Binbin CONG, Yuguang CHEN, Baowei DUAN, Yongsheng WANG
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Editorial Office of China Oncology 2023-02-01
Serie:	Zhongguo aizheng zazhi
Soggetti:	Breast cancer Sentinel lymph node biopsy Targeted axillary lymph node dissection Neoadjuvant treatment
Accesso online:	http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2023.02.011
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!